Friday, March 10, 2017 8:46:37 AM
Many MMJ stocks were weak yesterday
Again we did rally to 0.039, not that there was no rally. Bulk of the big buyers were at open, however as day progressed and most of the penny stocks are having low volume, momentum faded and MM used that opportunity to whack the bid and accumulate shares for DFCON pump
You guys need to look at how MM play with these stocks, they know well in advance when the next big event will help the stock, before that they will play these games to accumulate, then comes spike when they are done accumulating
VDRM is trading in steps with rest of the MMJ stocks. This is acting more like MMJ stock and not pure biotech play. the high volume rallies coincide with MMJ stock rallies across the board
MJ stocks have been correcting for many days now. See all MMJ stocks have dropped 50-60% and VDRM is in line with that. The volume has been low in many MJ stocks during this correction phase
(S@ING, OWCP, CNBX and many other)
The volume in all MMJ stock has been very low for many days as they are consolidating gains, most have dropped 50-60%, VDRM correction follows that pattern and consolidation phase is coming to an end, based on the chart, the stair step pattern - Points to spike soon !. Volume during this phase has been pretty low compared to 60-50 million volume we had during the rally to 0.07 - That's how stock consolidate during pullback on low volume. Medical MJ stocks will not be affected by Trump policies at all, so there is nothing to worry there. Buy only Medical MJ stocks if you want to invest in MJ sector This is however double
Biotech + Medical MJ
I see 80% Biotech and 20% MMJ based on their current product situation. They plan to use the delivery system for applying CBD based creams and they have started trials on those according to Doc, look for PR on that front very soon
I think consolidation phase is coming to an end and few of the MMJ stocks have started showing signs of rebound, OWC@P dropped from 3.2 to 1.2, CNB@X from 7.6 to 3, This one trading exactly in line with the Medical MJ stocks, I am not talking about recreational
However here is the game changer with VDRM
This is Biotech Play as well and with DFCON so close look for rise. Doc also told me in the email his main reason for hiring is attracting institutional investors during the conf. The hiring for production launch makes them ready and not purely in clinical stage phase
that's where this stock will act as biotech now since this is Diabetes + and DFCON presentation is more to attract investors and build awareness among investment community and hence the hire..
MMJ PR few days ago attracted many MMJ investors apart from biotech
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM